These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6980216)

  • 1. A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces.
    Ito T; Ezaki N; Ohba K; Amano S; Kondo Y; Miyado HS; Shomura T; Sezaki M; Niwa T; Kojima M; Inouye S; Yamada Y; Nida T
    J Antibiot (Tokyo); 1982 Apr; 35(4):533-5. PubMed ID: 6980216
    [No Abstract]   [Full Text] [Related]  

  • 2. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.
    Brown AG; Butterworth D; Cole M; Hanscomb G; Hood JD; Reading C; Rolinson GN
    J Antibiot (Tokyo); 1976 Jun; 29(6):668-9. PubMed ID: 950324
    [No Abstract]   [Full Text] [Related]  

  • 3. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.
    Hood JD; Box SJ; Verrall MS
    J Antibiot (Tokyo); 1979 Apr; 32(4):295-304. PubMed ID: 468716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [beta-lactamase inhibitors].
    Navashin SM; Nikolaeva TI; Rozenfel'd GS
    Antibiotiki; 1980 Jan; 25(1):51-67. PubMed ID: 6986839
    [No Abstract]   [Full Text] [Related]  

  • 5. Asparenomycin A, a new carbapenem antibiotic.
    Tanaka K; Shoji J; Terui Y; Tsuji N; Kondo E; Mayama M; Kawamura Y; Hattori T; Matsumoto K; Yoshida T
    J Antibiot (Tokyo); 1981 Jul; 34(7):909-11. PubMed ID: 6974725
    [No Abstract]   [Full Text] [Related]  

  • 6. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
    Box SJ; Hood JD; Spear SR
    J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.
    Butterworth D; Cole M; Hanscomb G; Rolinson GN
    J Antibiot (Tokyo); 1979 Apr; 32(4):287-94. PubMed ID: 468715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new olivanic acid derivative produced by Streptomyces olivaceus: isolation and structural studies.
    Box SJ; Corbett DF; Robins KG; Spear SR; Verrall MS
    J Antibiot (Tokyo); 1982 Oct; 35(10):1394-6. PubMed ID: 6983522
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the biosynthesis of clavulanic acid. I. Incorporation of 13C-labelled precursors.
    Elson SW; Oliver RS
    J Antibiot (Tokyo); 1978 Jun; 31(6):586-92. PubMed ID: 681240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of bacterial beta-lactamases by some monocyclic beta-lactams.
    Isaacs NS; Sunman G; Reading C
    J Antibiot (Tokyo); 1982 May; 35(5):589-93. PubMed ID: 6980873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PS-5, a new beta-lactam antibiotic from Streptomyces.
    Okamura K; Hirata S; Okumura Y; Fukagawa Y; Shimauchi Y; Kouno K; Ishikura T
    J Antibiot (Tokyo); 1978 May; 31(5):480-2. PubMed ID: 670088
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent chemical modification of beta-lactam antibiotics.
    Hashimoto M; Kamiya T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():218-29. PubMed ID: 612706
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors.
    Baltzer B; Binderup E; von Daehne W; Godtfredsen WO; Hansen K; Nielsen B; Sørensen H; Vangedal S
    J Antibiot (Tokyo); 1980 Oct; 33(10):1183-92. PubMed ID: 6969724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of carbapenems with a sulfonyl group in the C-6 side-chain and their biological activity.
    Tamura N; Natsugari H; Kawano Y; Matsushita Y; Yoshioka K; Ochiai M
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):996-1015. PubMed ID: 3496979
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening of new and novel beta-lactam antibiotics.
    Aoki H; Kunugita K; Hosoda J; Imanaka H
    Jpn J Antibiot; 1977 Dec; 30 Suppl():207-17. PubMed ID: 349191
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
    Ogawara H; Mantoku A
    J Antibiot (Tokyo); 1981 Oct; 34(10):1341-6. PubMed ID: 6975771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.
    Easton CJ; Knowles JR
    Biochemistry; 1982 Jun; 21(12):2857-62. PubMed ID: 7049231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and structure of a beta-lactamase inhibitor from Streptomyces.
    Maeda K; Takahashi S; Sezaki M; Iinuma K; Naganawa H; Kondo S; Ohno M; Umezawa H
    J Antibiot (Tokyo); 1977 Sep; 30(9):770-2. PubMed ID: 924900
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. II. Isolation, physico-chemical properties and structure determination.
    Chan JA; Shultis EA; Dingerdissen JJ; DeBrosse CW; Roberts GD; Snader KM
    J Antibiot (Tokyo); 1985 Feb; 38(2):139-44. PubMed ID: 3838979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between non-classical beta-lactam compounds and the beta-lactamases of Actinomadura R39 and Streptomyces albus G.
    Kelly JA; Frère JM; Duez C; Ghuysen JM
    Biochem J; 1981 Oct; 199(1):137-43. PubMed ID: 6978132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.